TLDR
- Teucrium’s 2x Short Daily XRP ETF has been postponed for the 19th consecutive time, with the effective date now set for October 11, 2026.
- SEC documentation offers no stated reasoning for the ongoing delays or any indication of regulatory disapproval.
- The firm’s 2x Long Daily XRP ETF, ticker XXRP, trades actively on exchanges, highlighting the disparity between the two products.
- Multiple leveraged XRP offerings from ProShares and Volatility Shares remain available to U.S. investors.
- Spot XRP ETFs demonstrate steady investor appetite, with major institutional players reporting holdings in XRP-related products.
Teucrium has extended the effective date for its anticipated 2x Short Daily XRP ETF once more, marking the 19th consecutive postponement. The recent SEC filing establishes October 11, 2026, as the new target date, continuing a pattern of extensions that started in 2025. This inverse leveraged product aims to deliver roughly double the opposite of XRP‘s daily returns. When XRP drops 1% in a single day, the fund targets approximately 2% gains, excluding management fees, tracking errors, and additional expenses.
Registration Statement Extended Through October
The October 11 deadline represents when the registration statement becomes effective rather than a confirmed market debut. Teucrium indicates the fund will commence public trading when circumstances allow following the effective date.
Documentation filed with the SEC reveals Teucrium has consistently submitted Form 485BXT amendments to extend the effective date. A summer filing explicitly stated its singular objective involved delaying effectiveness, moving the target to mid-August at that juncture.
These delay notifications lack explanatory details regarding the ongoing postponements of the bearish XRP ETF. The filings contain no language suggesting regulatory rejection or SEC-mandated delays.
The submissions present no referenced issues regarding market liquidity, prospective investor interest, or compliance challenges. Absent additional disclosure from Teucrium, the motivation driving these serial postponements stays unresolved.
Bullish XRP Funds Maintain Market Presence
Teucrium currently manages its 2x Long Daily XRP ETF under ticker XXRP. This leveraged product targets double XRP’s daily price movement and maintained trading activity through September 11, settling at $30.96 with transaction volume approaching 796,000 shares.
Teucrium keeps the inverse fund within its product lineup. An early August investment advisory document references both the bullish and bearish XRP vehicles, establishing identical 1.89% advisory compensation for each.
Additional leveraged XRP offerings operate within American markets. ProShares UXRP and Volatility Shares XRPT each deliver 2x long daily exposure to XRP price action, while multiple spot XRP ETFs facilitate direct asset exposure.
Appetite for XRP-focused ETF vehicles has persisted across market conditions. Recently launched U.S. spot XRP funds documented ongoing capital inflows throughout trading periods when XRP prices hovered around the $1.30 level.
Institutional disclosure documents have revealed XRP ETF positions from prominent firms such as Goldman Sachs, Jane Street, and Millennium Management. These reported allocations expand the spectrum of XRP-connected investment vehicles accessible to American market participants.
Regarding Teucrium’s inverse product, October 11 represents the upcoming milestone date. Following 19 successive extensions, the market still awaits definitive guidance on when the bearish XRP fund will begin trading.





